News Quantified

VKTX – viking therapeutics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Viking Therapeutics (VKTX) is now covered by Wolfe Research. They set a "peer perform" rating on the stock.

Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-2 Trial of VK2735 [Yahoo! Finance]

Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-2 Trial of VK2735

Why Viking Therapeutics, Inc. (VKTX) Dipped More Than Broader Market Today [Yahoo! Finance]

Why Viking Therapeutics Stock Could Take Off Later This Year [Yahoo! Finance]

0.3%

MISS

8.0%

MISS

0.9%

MISS

-1.1%

MISS

Form SCHEDULE 13G/A Viking Therapeutics, Filed by: VANGUARD GROUP INC

Form 4 Viking Therapeutics, For: Mar 10 Filed by: Aubuchon Neil William

Form 10-K Viking Therapeutics, For: Dec 31

Form 8-K Viking Therapeutics, For: Feb 11

Form 4 Viking Therapeutics, For: Jan 12 Filed by: Aubuchon Neil William

Top News Gainers

11/5 Viking Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update 19.0%

3/19 Viking Therapeutics Inc (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at William Blair. 8.1%

5/4 Viking Therapeutics Inc (NASDAQ: VKTX) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.2%

12/21 Viking Therapeutics Inc (NASDAQ: VKTX) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. 5.8%

4/3 Form 4 Viking Therapeutics, For: Mar 31 Filed by: MORNEAU MICHAEL 5.4%

11/12 Viking Therapeutics to Participate in Upcoming Investor Conferences 4.9%

10/31 Form 4 Viking Therapeutics, For: Oct 31 Filed by: MORNEAU MICHAEL 4.7%

3/17 Form 8-K Viking Therapeutics, For: Mar 17 3.7%

7/15 Viking Therapeutics Inc (NASDAQ: VKTX) is now covered by analysts at Citigroup Inc. They set an "outperform" rating on the stock. 3.5%

8/6 Viking Therapeutics Inc (VKTX) Q2 2019 Earnings Call Transcript [The Motley Fool] 2.6%

Top News Decliners

11/19 Viking launches mid-stage study of VK2809 in NASH; shares up 7% premarket [Seeking Alpha] -15.5%

3/21 Viking Therapeutics Inc (NASDAQ: VKTX) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -9.0%

1/3 Form 4 Viking Therapeutics, For: Jan 02 Filed by: SINGLETON J MATTHEW -9.0%

2/26 Form 10-K Viking Therapeutics, For: Dec 31 -8.7%

5/28 Viking Therapeutics to Participate in Upcoming Investor Conferences -8.2%

5/1 Viking Therapeutics Inc (NASDAQ: VKTX) is now covered by analysts at BTIG Research. They set a "buy" rating and a $9.00 price target on the stock. -7.6%

8/11 Is Viking Therapeutics a Buy? [The Motley Fool] -7.3%

8/1 Q2/2019 6/30/2019 EPS -0.110 ZacksConsensus -0.090 ActVsEst (0.020) - Miss -6.6%

5/7 3 Top Biotech Stocks to Buy in May [The Motley Fool] -6.2%

4/14 Viking Therapeutics Inc (NASDAQ: VKTX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.8%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day